News Industry News U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure June 26, 2019
News Industry News New Study Finds Abbott Blood Test Can Help Predict Future Cardiac Events In Adults With No Known Heart Disease April 29, 2019
News Industry News Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure February 25, 2019